The objective of the bill is to provide a legal status to the Centre so as to function independently as an autonomous body and also an 'institution of national importance' for education, training and research in the areas of biotechnology, a statement here said.
The Centre has already been established by an executive order of the Government of India in November, 2008 after the approval by the Union Cabinet. It is currently operational at the NCR Biotech Science Cluster, Faridabad and the enactment does not involve any financial implications at this stage, the statement added.
It would be a hub of biotechnology expertise in the countries in South Asian Association for Regional Cooperation (SAARC) region, and more generally in the Asia region, and to address human resources needs in the region, the statement said.
The Centre is an inter-disciplinary institution in life sciences and biotechnology and offers novel educational and training courses in the interdisciplinary and related areas of biotechnology, it added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
